Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

6(66.7%)

Phase 2

3(33.3%)

9Total

N/A(6)

Phase 2(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT07492342Phase 2Recruiting

Fulzerasib Sequential Sintilimab Plus Platinum-Doublet Neoadjuvant Therapy for Resectable KRAS G12C-Mutant NSCLC

Role: lead

NCT07377123Not ApplicableNot Yet Recruiting

Tubeless Spontaneous Ventilation Anesthesia in Kidney Transplantation

Role: lead

NCT07232394Not ApplicableCompleted

Early Feeding and Mobilization in Thoracic Surgery

Role: lead

NCT07201077Not ApplicableCompleted

ArticuGrasp Trial: New Flexible Tool vs Standard Grasper for Lung Cancer Node Removal in Keyhole Chest Surgery

Role: lead

NCT07177105Phase 2Not Yet Recruiting

Primary Tumor Resection With Sintilimab and Chemotherapy in Advanced NSCLC

Role: lead

NCT07177092Phase 2Not Yet Recruiting

Primary Tumor Resection Plus Osimertinib in Advanced EGFR-mutant Non-small Cell Lung Cancer

Role: lead

NCT07110259Not ApplicableNot Yet Recruiting

AI-Based DeepGEM Tool for Predicting Gene Mutations in NSCLC Patients: A Randomized Controlled Study

Role: lead

NCT05472350Not ApplicableUnknown

Efficacy and Safety of Perioperative Use of Breztri Aerosphere to Relieve Cough After Lobectomy

Role: lead

NCT04950907Not ApplicableUnknown

Uniportal Tubeless VATS for the Evaluation of Biopsy for Second-generation Sequencing in Patients With Advanced NSCLC

Role: lead

NCT02988141Unknown

EGFR-TKI Resistance Profile in Chinese Patients With Advanced EGFRm+ NSCLC

Role: lead

All 10 trials loaded